Haleon Says Attention Is A Good Measure Of Media Quality, But It's Too Soon To Make It A Buying Standard | AdExchanger
Briefly

from AdExchanger2 months ago
Haleon, which owns Advil, Tums, Sensodyne, and Flonase nasal spray, has been experimenting with attention measurement alongside its agency Publicis for the past 18 months, said Phil Jackson, Haleon's director of global digital marketing effectiveness innovation.
AdExchangerhttps://www.adexchanger.com/measurement/haleon-says-attention-is-a-good-measure-of-media-quality-but-its-too-soon-to-make-it-a-buying-standard/
The results of Haleon's recent test of Adelaide's attention scoring solution within Amazon's DSP could strengthen the case that low-attention inventory isn't worth buying.
AdExchangerhttps://www.adexchanger.com/measurement/haleon-says-attention-is-a-good-measure-of-media-quality-but-its-too-soon-to-make-it-a-buying-standard/
Read at AdExchanger
#haleon #attention-metrics #inventory-quality-measurement #amazon-dsp #campaign-performance
[
add
]
[
|
|
]